Research progress on drugs targeting the TGF-β signaling pathway in fibrotic diseases
2022 · Immunologic Research · 58 citations
https://doi.org/10.1007/s12026-022-09267-y
L
Longlong Luo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
72
Papers
611
Citations
14
h-index
17
i10-index
Longlong Luo is an academic researcher from Hunan Normal University. The author has contributed to research in topics: Viral Infections and Outbreaks Research & Monoclonal and Polyclonal Antibodies Research & Cancer Immunotherapy and Biomarkers. The author has an h-index of 14, co-authored 62 publications.
ORCID: 0000-0002-8307-6478Papers by this author
worksPharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularization
2014 · BMC Biotechnology · 17 citations
https://doi.org/10.1186/1472-6750-14-17
Generation of an ESRG Pr-tdTomato reporter human embryonic stem cell line, CSUe011-A, using CRISPR/Cas9 editing
2020 · Stem Cell Research · 7 citations
https://doi.org/10.1016/j.scr.2020.101983
Novel Quaternary Ammonium Salt‐Linked STING Agonist Antibody‐Drug Conjugate: Synergistic Activation of Tumor Immunity with Mitigated Off‐Target Toxicity
2025 · Advanced Science · 4 citations
https://doi.org/10.1002/advs.202502270
Unveiling novel insights into human IL-6 − IL-6R interaction sites through 3D computer-guided docking and systematic site mutagenesis
2024 · Scientific Reports · 3 citations
https://doi.org/10.1038/s41598-024-69429-w
Broad‐Spectrum Engineered Multivalent Nanobodies Against SARS‐CoV‐1/2
2024 · Advanced Science · 3 citations
https://doi.org/10.1002/advs.202402975
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat